RxDoctor Payments Data

Michael Washinsky

Family Medicine · Hazelton, PANPI 1801821194

Payments from drug & device makers

$13,413in general payments, 2019–2025

Across 725 payments — averaging $18.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$2K
  • Novo Nordisk$2K
  • AstraZeneca$1K
  • Pfizer$1K
  • Lilly USA, LLC$819
  • Boehringer Ingelheim$695
  • plus $5K from 28 others

What the payments were for

  • Food & beverage$13,31599%
  • Education$981%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,413 in reported general payments places this provider in the 95th percentile of 4,967 family medicine providers in Pennsylvania.

See all family medicine providers in Pennsylvania

Most prescribed under Part D

DrugClaimsCost to plans & patients
TradjentaLinagliptin21$17,994
JanuviaSitagliptin Phosphate13$13,451
Rosuvastatin Calcium90$1,128
Simvastatin108$1,027
Metoprolol Succinate56$987
Metformin Hcl ErMetformin Hcl27$940
Atorvastatin Calcium72$832
Pantoprazole Sodium45$728
Omeprazole56$687
Albuterol Sulfate HfaAlbuterol Sulfate11$635
Tamsulosin Hcl44$621
Levothyroxine Sodium50$609
Metformin Hcl55$529
Losartan Potassium31$507
Pravastatin Sodium22$453

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimTradjenta$695$17,99421 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,967 family medicine providers in Pennsylvania.

Other family medicine in Hazelton

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →